← Open Payments lookup

DEBORAH BAKER: Open Payments

NPI 1467630061 · BLUFFTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,849 in 108 payments from 16 companies in 2025. Trend: 2023 $1,930 · 2024 $1,676 · 2025 $1,849

Food & beverage: $1,639Education: $210
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.11$316
E.R. Squibb & Sons, L.L.C.22$288
Vanda Pharmaceuticals Inc.14$156
ABBVIE INC.9$151
Lundbeck LLC9$146
Alkermes, Inc.7$142
Otsuka America Pharmaceutical, Inc.6$117
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$101
Tris Pharma Inc6$100
Supernus Pharmaceuticals, Inc.4$74

Products named: REXULTI, AUSTEDO XR, COBENFY, VRAYLAR, ARISTADA, FANAPT, CAPLYTA, Dyanavel XR.

Industry payments across IN — which companies pay providers there.